Zephyrnet Logo

Biotechnology

Kenergy Scientific, Inc. Announces That It Has Acquired MedSmart Group, Inc.

BAY HARBOR ISLANDS, FL / ACCESSWIRE / July 7, 2020 / Kenergy Scientific Inc. (OTC PINK:KNSC) is pleased to announce it has executed...

Unum Therapeutics Forges Ahead with Acquisition of Kiq LLC

Unum Therapeutics announced on Monday that it has successfully completed its acquisition of Kiq LLC, a privately held biotechnology company with a...

Pacgen Announces Proposed Acquisition by General Biologicals Corporation

VANCOUVER, British Columbia, July 07, 2020 (GLOBE NEWSWIRE) -- Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS) announced today that it has...

Vor Biopharma Snags $110 Million to Advance AML Treatment into the Clinic

Vor Biopharma secured $110 million in a Series B financing round that will be used to advance the company’s lead stem cell-based...

Predictive Oncology Completes Acquisition of Quantitative MedicineAcquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and Development

MINNEAPOLIS, July 07, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine...

Regeneron Receives $450 Million BARDA Contract for COVID-19 Antibody Cocktail

Yesterday, Regeneron Pharmaceuticals, with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), announced it was launching Phase III trials of...

HiberCell Announces Acquisition of Biothera Pharmaceuticals’ Imprime PGG Program

NEW YORK, July 7, 2020 /PRNewswire/ -- HiberCell a biotechnology company developing novel therapeutics for cancer relapse and metastasis, today announced the acquisition of...

GSK, Medicago Forge Agreement to Develop Novel Adjuvanted COVID-19 Vaccine

Willy Barton / Shutterstock GlaxoSmithKline is providing its pandemic adjuvant technology to another company to bolster the chances of developing a vaccine...

MyoKardia: The Precision Cardiac Medicine Company with Diversity and Inclusion at its Heart

Putting your employees and company culture first keeps the focus on inclusion and innovation, giving the company an incredible competitive advantage. At...

ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020

PORTLAND, Maine, July 07, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures...

Cellectis’ CAR-T Trial for Multiple Myeloma on Clinical Hold After Patient Death

Cellectis, based in Paris and New York, announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on...

GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020Second Quarter 2020 Revenue Expected to Represent Approximately 118% Year-Over-Year Growth

CARLSBAD, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?